Electronic Drug Delivery System Market Overview:
Electronic drug delivery systems (EDDS) represents a trend in the advancement and development of drug delivery systems, that are interactive, portable, wirelessly connected and allow patient-administered therapy dropping overall healthcare cost. Insulin pump is one of the most commonly used Electronic Drug Delivery System which can be utilized for management of diabetes. The upgrading of patient adherence when using prescribed medication is one of the driving forces in the development of EDDS. Additionally, EDDS have shown the potential to offer targeted drug delivery to particular sites in the body. The EDDS can be used nowadays for appropriate administration of drug to the targeted site.
COVID-19 scenario analysis:
The medical supplies important to help in the management of the infected population would boost in the current scenario. There is various respiratory support devices such as life-support machine, atomizer, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Furthermore, COVID-19 has led to a steep increase in the demand for medical supplies such as personal protective equipment including gloves, masks, and protective eyeglasses. With surge in number of COVID-19 cases globally, the need for medical supplies keeps on growing among, both from healthcare professionals and also among the civil population for precautionary measures. The manufacturers of these personal protective products have a chance to capitalize this augmented demand of medical supplies to ensure adequate and also continuous supply of personal protective equipment in the market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The key factors are anticipated to help the market grow in the near future that include growth in the prevalence of target and advancements in technologies and innovation in designs of electronic drug delivery system. Furthermore, favorable reimbursement scenario in majority of the markets would help the industry propel in the near future. However, disadvantages that are associated with the electronic device operation and the functionality would help the electronic drug delivery system market boost in the near future.
New product advancements to flourish the market
The increase in the development of the products according to the need of the industry would help the market grow in the near future. For instance, in March 2020, Diabeloop of Grenoble, had developed an external Type 1 diabetes management system, called as DBLG1, that connects three components, which are a patch-like insulin pump, continuous glucose monitor, and an artificial intelligence handset that contains Diabeloop’s self-learning algorithm and user interface
In May 2017, Aptar Pharma, which is among the leader in innovative drug delivery systems announced the approval by the European Medicines Agency (EMA) of its first integrated electronic nasal lockout device (e-Lockout) and also following a multi-year development with Takeda Pharmaceuticals International AG. Furthermore, Aptar Pharma agreed to supply Takeda with its e-Lockout device for a multidose nasal spray version of Instanyl. The EMA had granted marketing authorization for this multidose nasal spray treatment called Instanyl DoseGuardTM.
Surge in mergers and acquisitions to boost the market
The growth in the mergers and acquisition would help the key market players to show their presence in the market and hence gain maximum shares in the forecast period. For instance, in July 2018, Swiss tech company Sensile Medical acquired by Gerresheimer, which is a glass and plastics manufacturer focusing in pharmaceutical packaging and drug delivery devices, with insulin pens and inhalers, in a deal worth up to €350 million with half upfront. The goal of merging the two companies includes developing new delivery systems with digital and electronic capabilities.
Key benefits of the report:
- This study presents the analytical depiction of the global electronic drug delivery system market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Electronic Drug Delivery System market share.
- The current market is quantitatively analyzed to highlight the global Electronic Drug Delivery System market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Electronic Drug Delivery System market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Electronic Drug Delivery System Market research report:
- What are the leading market players active in the Electronic Drug Delivery System market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in tasking further strategic steps?
Electronic Drug Delivery System Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Indication |
|
 By Region |
|
 Key Market Players | Insulet Corporation, Bayer AG, AstraZeneca, F. Hoffmann-La Roche, Medtronic plc., Merck Group Amgen, Tandem Diabetes Care, Companion Medical, Novo Nordisk, United Therapeutics Corporation |
Loading Table Of Content...
